PTJ
RCUS icon

Paul Tudor Jones’s Arcus Biosciences RCUS Stock Holding History

Paul Tudor Jones’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-216,311
Closed -$4.67M – 4149
2026
Q1 		$4.67M Buy
216,311
+7,672
+4% +$166K 0.01% 1211
2025
Q4 		$4.97M Buy
+208,639
New +$4.26M 0.01% 1155
2025
Q2 		– Sell
-53,466
Closed -$420K – 3672
2025
Q1 		$420K Buy
53,466
+10,498
+24% +$122K ﹤0.01% 2377
2024
Q4 		$640K Sell
42,968
-2,682
-6% -$43.8K ﹤0.01% 2046
2024
Q3 		$698K Buy
+45,650
New +$720K ﹤0.01% 1831
2023
Q4 		– Sell
-28,173
Closed -$506K – 2804
2023
Q3 		$506K Buy
+28,173
New +$566K 0.01% 1675
2021
Q4 		– Sell
-41,200
Closed -$1.44M – 2894
2021
Q3 		$1.44M Sell
41,200
-12,857
-24% -$400K 0.02% 929
2021
Q2 		$1.48M Buy
54,057
+46,796
+644% +$1.34M 0.03% 687
2021
Q1 		$204K Sell
7,261
-28,296
-80% -$985K ﹤0.01% 1427
2020
Q4 		$923K Buy
+35,557
New +$861K 0.03% 719
2020
Q3 		– Sell
-66,529
Closed -$1.65M – 1503
2020
Q2 		$1.65M Buy
+66,529
New +$1.8M 0.08% 307
2020
Q1 		– Sell
-13,423
Closed -$136K – 1272
2019
Q4 		$136K Buy
+13,423
New +$113K 0.01% 1038
2018
Q2 		– Sell
-27,723
Closed -$428K – 1199
2018
Q1 		$428K Buy
+27,723
New +$462K 0.01% 621

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Paul Tudor Jones's RCUS Position: Q2 2026 in Review

Paul Tudor Jones sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 216,311 shares — an estimated $4.67M sold.

Paul Tudor Jones first reported a position in RCUS in Q1 2018 and held it in 13 quarters. The position peaked at $4.97M in Q4 2025. 228 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Paul Tudor Jones reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 216,311 Arcus Biosciences shares in Q2 2026, an estimated $4.67M.
  • Paul Tudor Jones first reported a position in Arcus Biosciences in Q1 2018 and held it in 13 quarters.
  • Paul Tudor Jones's Arcus Biosciences position peaked at $4.97M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.